A Study of the Efficacy of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal Alcohol Syndrome or Effects.
Phase of Trial: Phase I
Latest Information Update: 12 Apr 2017
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 06 Apr 2017 Status changed from active, no longer recruiting to completed.
- 02 Dec 2014 Planned End Date changed from 1 Jun 2012 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 02 Dec 2014 Planned primary completion date changed from 1 Apr 2012 to 1 Jul 2015 as reported by ClinicalTrials.gov record.